Assessment of Budesonide MMX® effectiveness for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the prospective multi-center observational study CORE Practice

Grażyna Rydzewska  1     Kristine Paridaens  2     Silvio Danese  3     Maciej Jesionowski  4    
1 Central Clinical Hospital of the Ministry of Interior and Administration,Warsaw,Poland
2 Ferring Pharmaceuticals Centre S.A.,Saint-Prex,Switzerland
3 Humanitas Clinical and Research Center, IRCCS,Rozzano,Italy
4 Ferring Pharmaceuticals Poland,Warsaw,Poland

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing